HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Read this article in Polish Commentary from Polish edition Commentary from Polish edition Correspondence: Submit a response Correspondence: View responses Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chatterjee, A. Search for Related Content PubMed PubMed Citation Articles by Chatterjee, A. Related Collections All Clinical Neurology All Neuropsychology/Behavior Related Articles

Cosmetic neurology

The controversy over enhancing movement, mentation, and mood

From the Department of Neurology and the Center for Cognitive Neuroscience, The University of Pennsylvania, Philadelphia, PA.

Address correspondence and reprint requests to Dr. Anjan Chatterjee, Dept. of Neurology and the Center for Cognitive Neuroscience, The University of Pennsylvania, 3 West Gates, 3400 Spruce St., Philadelphia, PA 19104; e-mail: anjan{at}mail.med.upenn.edu

Advances in cognitive neuroscience and neuropharmacology are yielding exciting treatments for neurologic diseases. Many of these treatments are also likely to have uses for people without disease. Here, I review the ways in which medicine might make bodies and brains function better by modulating motor, cognitive, and affective systems. These potential "quality of life" interventions raise ethical concerns, some related to the individual and others related to society. Despite these concerns, I argue that major restraints on the development of cosmetic neurology are not likely. Neurologists and other clinicians are likely to encounter patient-consumers who view physicians as gatekeepers in their own pursuit of happiness.

Received January 8, 2004. Accepted in final form May 3, 2004.

See also pages 948 and 951

Related Articles

September 28 Highlights
Neurology 2004 63: 946-947. [Full Text] [PDF]

This article has been cited by other articles:

				A. Chatterjee Is it acceptable for people to take methylphenidate to enhance performance? No BMJ, June 18, 2009; 338(jun18_2): b1956 - b1956. [Full Text]

				M. J. Mehlman and J. W. Berg Human subjects protections in biomedical enhancement research: assessing risk and benefit and obtaining informed consent. J. Law Med. Ethics, September 1, 2008; 36(3): 546 - 549. [PDF]

				M. Nichter Coming to Our Senses: Appreciating the Sensorial in Medical Anthropology Transcultural Psychiatry, June 1, 2008; 45(2): 163 - 197. [Abstract] [PDF]

				A Chatterjee The promise and predicament of cosmetic neurology J. Med. Ethics, February 1, 2006; 32(2): 110 - 113. [Full Text] [PDF]

				M. Russo, C. Maher, W. Campbell, A. Chatterjee, R. H. Dees, and S. Hauser Cosmetic neurology: The controversy over enhancing movement, mentation, and mood Neurology, April 12, 2005; 64(7): 1320 - 1320. [Full Text] [PDF]

				Reviews of Note Journal Watch Psychiatry, November 18, 2004; 2004(1118): 6 - 6. [Full Text]

				S. L. Hauser The shape of things to come Neurology, September 28, 2004; 63(6): 948 - 950. [Full Text] [PDF]

				R. H. Dees Slippery slopes, wonder drugs, and cosmetic neurology: The neuroethics of enhancement Neurology, September 28, 2004; 63(6): 951 - 952. [Full Text] [PDF]

Correspondence: